Iscador Qu for chronic hepatitis C: an exploratory study [abstract]

Simple item page
dc.contributor.authorTusenius, K.J.
dc.contributor.authorSpoek, J.M.
dc.contributor.authorKramers, C.W.
dc.date.accessioned2024-05-23T18:58:44Z
dc.date.available2024-05-23T18:58:44Z
dc.date.digitized2019-01-14 10:51:17
dc.date.issued2001
dc.description.abstract<h2>Abstract</h2> <p>Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6–20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.</p> <p><strong>Citation</strong>: Tusenius, K. J., Spoek, J. M., &amp; Kramers, C. W. (2001). Iscador Qu for chronic hepatitis C: An exploratory study. <em>Complementary Therapies in Medicine</em>, <em>9</em>(1), 12–16. <a href="https://doi.org/10.1054/ctim.2000.0408" target="_blank">https://doi.org/10.1054/ctim.2000.0408</a></p> <p>[not open access]</p>
dc.description.notesfixed
dc.identifier.citationTusenius, K. J., Spoek, J. M., & Kramers, C. W. (2001). Iscador Qu for chronic hepatitis C: An exploratory study. Complementary Therapies in Medicine, 9(1), 12–16. https://doi.org/10.1054/ctim.2000.0408
dc.identifier.doihttps://doi.org/10.1054/ctim.2000.0408
dc.identifier.externalUrl/library/2019/1/4/iscador-qu-for-chronic-hepatitis-c-an-exploratory-study
dc.identifier.urihttps://hdl.handle.net/20.500.14430/614
dc.subject.otherhepatitis
dc.subject.otherviral load reduction
dc.subject.otherhepatic enzymes
dc.subject.otherSafety
dc.subject.otherMistletoe
dc.titleIscador Qu for chronic hepatitis C: an exploratory study [abstract]
dspace.entity.typePublication
oaire.citation.titleComplementary Therapies in Med
Files
Collections
01 Anthroposophic medicine (AM), therapies and health